Skip to Main Content
Skip Nav Destination

This chapter focuses on trypanosomiasis and leishmaniasis and demonstrates how comparative genetic and genomic analyses have informed and will continue to empower diagnostics discovery, and have led to the development of low-cost, point-of-care, rapid diagnostic tests, with both clinical and research applications. Also highlighted is the still underexploited potential of a systematic combined ‘omics’ approach to both the identification of candidate vaccines and production of prototype diagnostics.

You do not currently have access to this chapter, but see below options to check access via your institution or sign in to purchase.
Don't already have an account? Register
Close Modal

or Create an Account

Close Modal
Close Modal